MC1R, ASIP, TYR, and TYRP1 gene variants in a population-based series of multiple primary melanomas

Genes Chromosomes and Cancer

Volumn 51, Issue 7, 2012, Pages 654-661

  Helsing, Per ^a   Nymoen, Dag A ^a   Rootwelt, Helge ^a   Vårdal, Mari ^a   Akslen, Lars A ^b,c   Molven, Anders ^b,c   Andresen, Per A ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ASIP PROTEIN; MC1R PROTEIN; PROTEIN; TYR PROTEIN; TYRP1 PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ASSOCIATION; BLOOD DONOR; CANCER PATIENT; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; MULTIPLE PRIMARY MELANOMA; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; AGOUTI SIGNALING PROTEIN; FEMALE; HAIR COLOR; HAPLOTYPES; HUMANS; MALE; MELANOMA; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; MONOPHENOL MONOOXYGENASE; NORWAY; ODDS RATIO; OXIDOREDUCTASES; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR, MELANOCORTIN, TYPE 1; SKIN NEOPLASMS;

EID: 84860700714     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.21952     Document Type: Article

References (36)

1. Abdel-Malek ZA, Knittel J, Kadekaro AL, Swope VB, Starner R. 2008. The melanocortin 1 receptor and the UV response of human melanocytes: A shift in paradigm. Photochem Photobiol 84: 501-508.
2. Bastiaens MT, ter Huurne JA, Kielich C, Gruis NA, Westendorp RG, Vermeer BJ, Bavinck JN; Leiden Skin Cancer Study Team. 2001. Melanocortin-1 receptor gene variants determine the risk of nonmelanoma skin cancer independently of fair skin and red hair. Am J Hum Genet 68: 884-894.
3. Barrett JC, Fry B, Maller J, Daly MJ. 2005. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265.
4. Begg CB, Berwick M. 1997. A note on the estimation of relative risks of rare genetic susceptibility markers. Cancer Epidemiol Biomarkers Prev 6: 99-103.
5. Böhm M, Luger TA, Tobin DJ, García-Borrón JC. 2006. Melanocortin receptor ligands: New horizons for skin biology and clinical dermatology. J Invest Dermatol 126: 1966-1975.
6. Box NF, Duffy DL, Chen W, Stark M, Martin NG, Sturm RA, Hayward NK. 2001. MC1R genotype modifies risk of melanoma in families segregating CDKN2A mutations. Am J Hum Genet 69: 765-773.
7. Debniak T, Scott R, Masojc B, Serrano-Fernández P, Huzarski T, Byrski T, Debniak B, Górski B, Cybulski C, Medrek K, Kurzawski G, van de Wetering T, Maleszka R, Kladny J, Lubinski J. 2006. MC1R common variants, CDKN2A and their association with melanoma and breast cancer risk. Int J Cancer 119: 2597-2602.
8. Demenais F, Mohamdi H, Chaudru V, Goldstein AM, Newton Bishop JA, Bishop DT, Kanetsky PA, Hayward NK, Gillanders E, Elder DE, Avril MF, Azizi E, van Belle P, Bergman W, Bianchi-Scarrà G, Bressac-de Paillerets B, Calista D, Carrera C, Hansson J, Harland M, Hogg D, Höiom V, Holland EA, Ingvar C, Landi MT, Lang JM, Mackie RM, Mann GJ, Ming ME, Njauw CJ, Olsson H, Palmer J, Pastorino L, Puig S, Randerson-Moor J, Stark M, Tsao H, Tucker MA, van der Velden P, Yang XR, Gruis N; Melanoma Genetics Consortium. 2010. Association of MC1R variants and host phenotypes with melanoma risk in CDKN2A mutation carriers: A GenoMEL study. J Natl Cancer Inst 102: 1568-1583.
9. Fargnoli MC, Altobelli E, Keller G, Chimenti S, Höfler H, Peris K. 2006. Contribution of melanocortin-1 receptor gene variants to sporadic cutaneous melanoma risk in a population in central Italy: A case-control study. Melanoma Res 16: 175-182.
10. Fargnoli MC, Gandini S, Peris K, Maisonneuve P, Raimondi S. 2010. MC1R variants increase melanoma risk in families with CDKN2A mutations: A meta-analysis. Eur J Cancer 46: 1413-1420.
11. Gerstenblith MR, Goldstein AM, Fargnoli MC, Peris K, Landi MT. 2007. Comprehensive evaluation of allele frequency differences of MC1R variants across populations. Hum Mutat 28: 495-505.
12. Goldstein AM, Landi MT, Tsang S, Fraser MC, Munroe DJ, Tucker MA. 2005. Association of MC1R variants and risk of melanoma in melanoma-prone families with CDKN2A mutations. Cancer Epidemiol Biomarkers Prev 14: 2208-2212.
13. Gudbjartsson DF, Sulem P, Stacey SN, Goldstein AM, Rafnar T, Sigurgeirsson B, Benediktsdottir KR, Thorisdottir K, Ragnarsson R, Sveinsdottir SG, Magnusson V, Lindblom A, Kostulas K, Botella-Estrada R, Soriano V, Juberías P, Grasa M, Saez B, Andres R, Scherer D, Rudnai P, Gurzau E, Koppova K, Kiemeney LA, Jakobsdottir M, Steinberg S, Helgason A, Gretarsdottir S, Tucker MA, Mayordomo JI, Nagore E, Kumar R, Hansson J, Olafsson JH, Gulcher J, Kong A, Thorsteinsdottir U, Stefansson K. 2008. ASIP and TYR pigmentation variants associate with cutaneous melanoma and basal cell carcinoma. Nat Genet 40: 886-891.
14. Helsing P, Høyheim B. 2001. The Asp84Glu variant of the MC1R gene in Norwegian melanoma patients. Acta Derm Venereol 81: 68-69.
15. Helsing P, Nymoen DA, Ariansen S, Steine SJ, Maehle L, Aamdal S, Langmark F, Loeb M, Akslen LA, Molven A, Andresen PA. 2008. Population-based prevalence of CDKN2A and CDK4 mutations in patients with multiple primary melanomas. Genes Chromosomes Cancer 47: 175-184.
16. Höiom V, Tuominen R, Käller M, Lindén D, Ahmadian A, Månsson-Brahme E, Egyhazi S, Sjöberg K, Lundeberg J, Hansson J. 2009. MC1R variation and melanoma risk in the Swedish population in relation to clinical and pathological parameters. Pigment Cell Melanoma Res 22: 196-204.
17. Hussussian CJ, Struewing JP, Goldstein AM, Higgins PA, Ally DS, Sheahan MD, Clark WH, Jr., Tucker MA, Dracopoli NC. 1994. Germline p16 mutations in familial melanoma. Nat Genet 8: 15-21.
18. Johnson TM, Hamilton T, Lowe L. 1998. Multiple primary melanomas. J Am Acad Dermatol 39: 422-427.
19. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stockert E, Day RS, III, Johnson BE, Skolnick MH. 1994. A cell cycle regulator potentially involved in genesis of many tumor types. Science 264: 436-440.
20. Kanetsky PA, Rebbeck TR, Hummer AJ, Panossian S, Armstrong BK, Kricker A, Marrett LD, Millikan RC, Gruber SB, Culver HA, Zanetti R, Gallagher RP, Dwyer T, Busam K, From L, Mujumdar U, Wilcox H, Begg CB, Berwick M. 2006. Population-based study of natural variation in the melanocortin-1 receptor gene and melanoma. Cancer Res 66: 9330-9337.
21. Kanetsky PA, Panossian S, Elder DE, Guerry D, Ming ME, Schuchter L, Rebbeck TR. 2010. Does MC1R genotype convey information about melanoma risk beyond risk phenotypes? Cancer 116: 2416-2428.
22. Kennedy C, ter Huurne J, Berkhout M, Gruis N, Bastiaens M, Bergman W, Willemze R, Bavinck JN. 2001. Melanocortin 1 receptor (MC1R) gene variants are associated with an increased risk for cutaneous melanoma which is largely independent of skin type and hair color. J Invest Dermatol 117: 294-300.
23. Knappskog S, Geisler J, Arnesen T, Lillehaug JR, Lønning PE. 2006. A novel type of deletion in the CDKN2A gene identified in a melanoma-prone family. Genes Chromosomes Cancer 45: 1155-1163.
24. Matichard E, Verpillat P, Meziani R, Gérard B, Descamps V, Legroux E, Burnouf M, Bertrand G, Bouscarat F, Archimbaud A, Picard C, Ollivaud L, Basset-Seguin N, Kerob D, Lanternier G, Lebbe C, Crickx B, Grandchamp B, Soufir N. 2004. Melanocortin 1 receptor (MC1R) gene variants may increase the risk of melanoma in France independently of clinical risk factors and UV exposure. J Med Genet 41: e13.
25. Molven A, Grimstvedt MB, Steine SJ, Harland M, Avril MF, Hayward NK, Akslen LA. 2005. A large Norwegian family with inherited malignant melanoma, multiple atypical nevi, and CDK4 mutation. Genes Chromosomes Cancer 44: 10-18.
26. Palmer JS, Duffy DL, Box NF, Aitken JF, O'Gorman LE, Green AC, Hayward NK, Martin NG, Sturm RA. 2000. Melanocortin-1 receptor polymorphisms and risk of melanoma: Is the association explained solely by pigmentation phenotype? Am J Hum Genet 66: 176-186.
27. Pastorino L, Bonelli L, Ghiorzo P, Queirolo P, Battistuzzi L, Balleari E, Nasti S, Gargiulo S, Gliori S, Savoia P, Abate Osella S, Bernengo MG, Bianchi Scarrà G. 2008. CDKN2A mutations and MC1R variants in Italian patients with single or multiple primary melanoma. Pigment Cell Melanoma Res 21: 700-709.
28. Pérez Oliva AB, Fernéndez LP, Detorre C, Herráiz C, Martínez-Escribano JA, Benítez J, Lozano Teruel JA, García-Borrón JC, Jiménez-Cervantes C, Ribas G. 2009. Identification and functional analysis of novel variants of the human melanocortin 1 receptor found in melanoma patients. Hum Mutat 30: 811-822.
29. Peris K, Fargnoli MC, Pacifico A, Surrenti T, Stolz W, Wolf P, Soyer HP, Chimenti S. 2004. CDKN2A and MC1R mutations in patients with sporadic multiple primary melanoma. J Invest Dermatol 122: 1327-1330.
30. Raimondi S, Sera F, Gandini S, Iodice S, Caini S, Maisonneuve P, Fargnoli MC. 2008. MC1R variants, melanoma and red hair color phenotype: A meta-analysis. Int J Cancer 122: 2753-2760.
31. Sturm RA, Duffy DL, Box NF, Newton RA, Shepherd AG, Chen W, Marks LH, Leonard JH, Martin NG. 2003. Genetic association and cellular function of MC1R variant alleles in human pigmentation. Ann N Y Acad Sci 994: 348-358.
32. Sulem P, Gudbjartsson DF, Stacey SN, Helgason A, Rafnar T, Magnusson KP, Manolescu A, Karason A, Palsson A, Thorleifsson G, Jakobsdottir M, Steinberg S, Pálsson S, Jonasson F, Sigurgeirsson B, Thorisdottir K, Ragnarsson R, Benediktsdottir KR, Aben KK, Kiemeney LA, Olafsson JH, Gulcher J, Kong A, Thorsteinsdottir U, Stefansson K. 2007. Genetic determinants of hair, eye and skin pigmentation in Europeans. Nat Genet 39: 1443-1452.
33. Sulem P, Gudbjartsson DF, Stacey SN, Helgason A, Rafnar T, Jakobsdottir M, Steinberg S, Gudjonsson SA, Palsson A, Thorleifsson G, Pálsson S, Sigurgeirsson B, Thorisdottir K, Ragnarsson R, Benediktsdottir KR, Aben KK, Vermeulen SH, Goldstein AM, Tucker MA, Kiemeney LA, Olafsson JH, Gulcher J, Kong A, Thorsteinsdottir U, Stefansson K. 2008. Two newly identified genetic determinants of pigmentation in Europeans. Nat Genet 40: 835-837.
34. Suzuki I, Tada A, Ollmann MM, Barsh GS, Im S, Lamoreux ML, Hearing VJ, Nordlund JJ, Abdel-Malek ZA. 1997. Agouti signaling protein inhibits melanogenesis and the response of human melanocytes to alpha-melanotropin. J Invest Dermatol 108: 838-842.
35. Van der Velden PA, Sandkuijl LA, Bergman W, Pavel S, van Mourik L, Frants RR, Gruis NA. 2001. Melanocortin-1 receptor variant R151C modifies melanoma risk in Dutch families with melanoma. Am J Hum Genet 69: 774-779.
36. Zuo L, Weger J, Yang Q, Goldstein AM, Tucker MA, Walker GJ, Hayward N, Dracopoli NC. 1996. Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma. Nat Genet 12: 97-99.